177 related articles for article (PubMed ID: 36910472)
1. Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition.
Sung DC; Chen M; Dominguez MH; Mahadevan A; Chen X; Yang J; Gao S; Ren AA; Tang AT; Mericko P; Patton R; Lee M; Jannaway M; Nottebaum A; Vestweber D; Scallan JP; Kahn ML
Nat Cardiovasc Res; 2022 Nov; 1(11):1006-1021. PubMed ID: 36910472
[TBL] [Abstract][Full Text] [Related]
2. VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling.
Harris NR; Nielsen NR; Pawlak JB; Aghajanian A; Rangarajan K; Serafin DS; Farber G; Dy DM; Nelson-Maney NP; Xu W; Ratra D; Hurr SH; Qian L; Scallan JP; Caron KM
Circ Res; 2022 Jan; 130(1):5-23. PubMed ID: 34789016
[TBL] [Abstract][Full Text] [Related]
3. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
4. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
5. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells.
Suzuki H; Watabe T; Kato M; Miyazawa K; Miyazono K
Blood; 2005 Mar; 105(6):2372-9. PubMed ID: 15561887
[TBL] [Abstract][Full Text] [Related]
6. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low density lipoprotein in the liver causes decreased permeability of liver lymphatic- but not liver sinusoidal-endothelial cells
Goldberg AR; Ferguson M; Pal S; Cohen R; Orlicky DJ; McCullough RL; Rutkowski JM; Burchill MA; Tamburini BAJ
Front Physiol; 2022; 13():1021038. PubMed ID: 36338478
[TBL] [Abstract][Full Text] [Related]
9. Remodeling Lymphatic Vessels in Intrinsically Aged Skin on SKH-1 Mouse Using Low Dose 5-aminolevulinic Acid Photodynamic Therapy via VEGF-C/VEGFR3 Pathway.
Yang Y; Shen S; Cao Y; Wang D; Kang Z; Wang P; Wang X
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102851. PubMed ID: 35398260
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds.
Hägerling R; Hoppe E; Dierkes C; Stehling M; Makinen T; Butz S; Vestweber D; Kiefer F
EMBO J; 2018 Nov; 37(22):. PubMed ID: 30297530
[TBL] [Abstract][Full Text] [Related]
11. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
12. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH; Bennett AM; Jin ZG
J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
[TBL] [Abstract][Full Text] [Related]
13. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
14. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
[TBL] [Abstract][Full Text] [Related]
15. Profibrotic VEGFR3-Dependent Lymphatic Vessel Growth in Autoimmune Valvular Carditis.
Osinski V; Yellamilli A; Firulyova MM; Zhang MJ; Peck AL; Auger JL; Faragher JL; Marath A; Voeller RK; O'Connell TD; Zaitsev K; Binstadt BA
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):807-821. PubMed ID: 38269589
[TBL] [Abstract][Full Text] [Related]
16. Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.
Hsu MC; Pan MR; Hung WC
Cells; 2019 Mar; 8(3):. PubMed ID: 30901976
[TBL] [Abstract][Full Text] [Related]
17. [Effects of three inducing factors on differentiation of bone marrow derived mesenchymal stem cells into lymphatic endothelial cells].
Wang YH; Xue B
Zhonghua Shao Shang Za Zhi; 2019 Feb; 35(2):125-133. PubMed ID: 30798579
[No Abstract] [Full Text] [Related]
18. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
19. VEGFR3 does not sustain retinal angiogenesis without VEGFR2.
Zarkada G; Heinolainen K; Makinen T; Kubota Y; Alitalo K
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):761-6. PubMed ID: 25561555
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
